
Raymond Wadlow MD
@raymondwadlowmd
Co-Director, Gastrointestinal Oncology Research and Program Director, Hematology-Oncology Fellowship, Inova Schar Cancer Institute
ID: 784020367677480960
06-10-2016 13:19:56
71 Tweet
285 Followers
455 Following

Great start of Saturday morning. #CRC #NRG2021 #NRGONC Thomas George, MD, FACP, FASCO opening remarks!!


Most prevalent #GImalignancy after #colorectal is #NETs and the incidence is rising says Yoomi Lee OncLive SOSS #ipc #mom with chair Raymond Wadlow MD Inova Schar Cancer Institute patients with a lower Ki67 got more benefit out of lanreotide. PRRT used in NETTER1 w/RR18%


Still a very deadly disease #pancreaticcancer with no readily available screening process and tends to present with symptoms and therefore advanced says Raymond Wadlow MD chair OncLive SOSS #ipc Inova Schar Cancer Institute #gism litany of failed efforts in trials. #sadness


Rapidly changing field of #hcc according to arthur winer the sixth most common cancer worldwide and rising in the US OncLive SOSS #ipc chair Raymond Wadlow MD Inova Schar Cancer Institute targeting the liver and tumors blood supply is a valid target. ?immune chkpt i


What impact does the diagnosis of a #gastrointestinalcancer diagnosis have on a patient’s psycho/social wellbeing asks Jennifer Bires OncLive SOSS #ipc with chair Raymond Wadlow MD Inova Schar Cancer Institute there is a life with #cancer program at Inova


Experts from Inova Schar Cancer Institute answer questions from the community on #gicancers OncLive SOSS #ipc chair Raymond Wadlow MD with arthur winer Yoomi Lee Jennifer Bires increase in younger patients receiving diagnosis of #colorectalcancer #sadness


Drug Approvals in Hepatocellular Carcinoma ja.ma/3aAJhyO via JAMA Oncology part of JAMA Network Options are great, but patients deserve studies designed with a more holistic understanding of the treatment landscape

Enjoyed #ACGME2021 session for new program directors with invaluable info on CCCs, Milestones, PECs and more from Natasha Bray @dr_c_cable and colleagues









#equityintrials This came up this week re neutropenia criteria. 10% of black patients have benign hereditary neutropenia and pt excluded if threshold is set at 1500. given no sponsor wiggle room! National Cancer Institute Dr. Cathy Eng Karyn Goodman, MD, MS SWOG Cancer Research Network ECOG-ACRIN Cancer Research Group systematic ways to address?

"“We still do not know the genetic cause of pancreatic cancer in the majority of families with multiple members affected with the disease.” -Diane M. Simeone, MD" ascopost.com/issues/decembe… via The ASCO Post

Discover all classes, groups, and special events offered by Inova Peterson Life with Cancer on the new and improved calendar and registration website! Register for several FREE classes and groups from anywhere, anytime! Discover and register: events.lifewithcancer.org! #cancercare #cancersupport
